The differentiation antigen NY-BR-1 is a
β
Inka Seil; Claudia Frei; Holger SΓΌltmann; Shirley K. Knauer; Knut Engels; Elke J
π
Article
π
2007
π
John Wiley and Sons
π
French
β 976 KB
## Abstract Antibodyβbased cancer immunotherapy relies on the identification and characterization of target antigens and the development of potent antibodies recognizing the target. Here we report the expression analysis and molecular characterization of the differentiation antigen NYβBRβ1, which w